Target Price | $481.56 |
Price | $420.94 |
Potential |
14.40%
register free of charge
|
Number of Estimates | 18 |
18 Analysts have issued a price target Elevance Health 2026 .
The average Elevance Health target price is $481.56.
This is
14.40%
register free of charge
$625.00
48.48%
register free of charge
$405.00
3.79%
register free of charge
|
|
A rating was issued by 24 analysts: 17 Analysts recommend Elevance Health to buy, 6 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Elevance Health stock has an average upside potential 2026 of
14.40%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 176.81 | 192.67 |
3.19% | 8.97% | |
Net Margin | 3.30% | 3.78% |
1.33% | 14.41% |
16 Analysts have issued a sales forecast Elevance Health 2025 . The average Elevance Health sales estimate is
This results in the following potential growth metrics:
9 Elevance Health Analysts have issued a net profit forecast 2025. The average Elevance Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 25.68 | 32.03 |
1.82% | 24.73% | |
P/E | 13.14 | |
EV/Sales | 0.62 |
9 Analysts have issued a Elevance Health forecast for earnings per share. The average Elevance Health <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Elevance Health stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Elevance Health...
Analyst | Rating | Action | Date |
---|---|---|---|
Argus Research |
Locked
➜
Locked
|
Locked | Jan 29 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jan 28 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Jan 24 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Jan 24 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Nov 05 2024 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 04 2024 |
Analyst Rating | Date |
---|---|
Locked
Argus Research:
Locked
➜
Locked
|
Jan 29 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jan 28 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Jan 24 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Jan 24 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Jan 06 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Nov 05 2024 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 04 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.